The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Open accessAbstract
EZ Inhibition: Missense mutations in the core constituents of the genome packaging material, chromatin, have been implicated in several of human cancers. Nucleosomes are made up of histones, and a mutation of lysine 27 (K27) to methionine in the N-terminal tail of histone variants H3.3 and H3.1 has been identified in various pediatric gliomas. Lewis et al. (p. 857 , published online 28 March; see the Perspective by Morgan and Shilatifard ) show that the polycomb enzyme complex, which can epigenetically modify K27 by addition of a methyl group—and which is often a silencing signal—is itself potently inhibited by replacement of the H3.3/3.1 K27 by methionine. The inhibition of the EZH2 subunit causes an overall reduction of K27 methylation. Methionine mutants of other methylated lysine residues in histone H3 cause similar reductions in methylation levels of the cognate lysine, altering the epigenetic profiles of such cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consequently, tumor cells with the K27M mutation exhibit low levels of H3K27me3 and aberrant gene silencing (4,(7)(8)(9).”
From S -adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3 (2016) · cites this paper as [7]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“act in a dominant manner to deplete H3K27 methylation by inhibiting PRC2 methyltransferase activity [5, 6]”
From Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling (2014) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“Additional histone H3 lysine-to-methionine mutants possess dominant gain-of-function activities [6]”
From Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling (2014) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“We and others previously showed that K-to-M oncohistones transform the histone H3 proteins into potent inhibitors of specific lysine methyltransferase enzymes (4-7).”
From S -adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3 (2016) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“Previous studies showed that the K27M mutation found in pediatric glioma is sufficient to transform histone H3 into a potent inhibitor of enzymatic activity of PRC2 (4, 5, 7).”
From S -adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3 (2016) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“we previously showed that H3K9M peptides are capable of inhibiting activity of SUV39H1 and G9a, two H3K9-directed methyltransferases, in vitro (7).”
From S -adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3 (2016) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“Previously, we found that only long, unbranched hydrophobic side chains containing methionine (M) and isoleucine (I) at lysine 27 (K27M and K27I) were capable of inhibiting PRC2 in vitro and decreasing H3K27me3 when expressed ectopically in cultured cells (7).”
From S -adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3 (2016) · cites this paper as [7]
In the citing paper
“Despite reports supporting a higher affinity of PRC2 for H3K27M as compared with wild-type H3 108-110 , H3K27M was often inversely correlated with PRC2 occupancy, challenging the idea that H3K27M sequesters PRC2 on chromatin 111,112 .”
From The roles of DNA, RNA and histone methylation in ageing and cancer (2019) · cites this paper as [112]
In the citing paper
“Expression of the histone mutant is accompanied by a reduction in the levels of Polycomb Repressive Complex 2 (PRC2) mediated H3K27 trimethylation (H3K27me3) and this is purported to be a driving event of DIPG oncogenesis4,5.”
From Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas (2017) · cites this paper as [4]
In the citing paper
“Interestingly upon loss of H3K27me3 these nucleosomes acquire H3K27ac resulting in the formation of H3K27M-K27ac heterotypic nucleosomes4 (Figure 1D and Supplementary Fig. 5B–C).”
From Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas (2017) · cites this paper as [4]
In the citing paper
“As shown by our group and others, H3K27M expression is associated with increased levels of H3K27ac4,5 (Fig. 1D).”
From Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas (2017) · cites this paper as [4]
In the citing paper
“Although still functionally active, PRC2 catalytic property toward H3K27M containing nucleosomes is strongly inhibited4.”
From Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas (2017) · cites this paper as [4]
In the citing paper
“Collectively, these results strongly indicate that H3K27M in DIPG cells does not appear to recruit or sequester EZH2 (or in general PRC2), as suggested by other studies4,6,7.”
From Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas (2017) · cites this paper as [4]
In the citing paper
“Attempts to model H3.3K27M-driven HGG formation in vivo via genetic recombination in neural progenitor/stem cells (NPCs) in the postnatal brain failed to demonstrate tumor-driving activity”
From H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas (2017) · cites this paper as Lewis et al., 2013
In the citing paper
“H3.3K27M has been shown to have gain-of-function activity inhibiting the Polycomb Repressive Complex 2 (PRC2) (Bender et al., 2013; Lewis et al., 2013), which in turn leads to a global reduction in H3K27me3 levels in primary tumors and tumor-derived primary cells.”
From H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas (2017) · cites this paper as Lewis et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Polycomb complex PRC2 and its mark in life
Margueron, R., & Reinberg, D. (2011) · Nature · doi:10.1038/nature09784 · Cited by 3,347
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631
St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2012) · Nature Genetics · doi:10.1038/ng.1102 · Cited by 1,724
Taverna, S. D., Li, H., Ruthenburg, A. J., Allis, C. D., & Patel, D. J. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1338 · Cited by 1,476
Self-citationRole of the polycomb protein EED in the propagation of repressive histone marks
Margueron, R., Justin, N., Ohno, K., Sharpe, M. L., Son, J., Drury, W. J., Voigt, P., Martin, S. R., Taylor, W. R., Marco, V. D., et al. (2009) · Nature · doi:10.1038/nature08398 · Cited by 1,281
Khuong-Quang, D.-A., Buczkowicz, P., Rakopoulos, P., Liu, X.-Y., Fontebasso, A. M., Bouffet, E., Bartels, U., Albrecht, S., Schwartzentruber, J., Letourneau, L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0998-0 · Cited by 1,028
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Simon, J. A., & Lange, C. A. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.07.010 · Cited by 880
Sneeringer, C. J., Scott, M. P., Kuntz, K. W., Knutson, S. K., Pollock, R. M., Richon, V. M., & Copeland, R. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012525107 · Cited by 719
Yap, D., Chu, J., Berg, T., Schapira, M., Cheng, S., Moradian, A., Morin, R. D., Mungall, A. J. J., Meissner, B., Boyle, M., et al. (2010) · Blood · doi:10.1182/blood-2010-11-321208 · Cited by 633
A Novel Mammalian Flavin-dependent Histone Demethylase
Karytinos, A., Forneris, F., Profumo, A., Ciossani, G., Battaglioli, E., Binda, C., & Mattevi, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003087 · Cited by 274
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 999
Romero, P., Richart, L., Aflaki, S., Petitalot, A., Burton, M., Michaud, A., Masliah‐Planchon, J., Kuhnowski, F., Cam, S. L., Baliñas-Gavira, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47701-x · Cited by 29
RNase P protein subunit Rpp29 represses histone H3.3 nucleosome deposition
Newhart, A., Powers, S. L., Shastrula, P. K., Sierra, I., Joo, L. M., Hayden, J. E., Cohen, A. R., & Janicki, S. M. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-02-0099 · Cited by 26
Recent Structural Insights into Polycomb Repressive Complex 2 Regulation and Substrate Binding
Kasinath, V., Poepsel, S., & Nogales, E. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b01064 · Cited by 27
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children
Pearson, A. D. J., Stegmaier, K., Bourdeaut, F., Reaman, G. H., Heenen, D. L., Meyers, M. L., Armstrong, S. A., Brown, P. A., Carvalho, D. D. D., Jabado, N., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.08.014 · Cited by 26
Lewis, N., Klein, R. H., Kelly, C., Yee, J. Q., & Knoepfler, P. S. (2022) · Epigenetics & Chromatin · doi:10.1186/s13072-022-00447-6 · Cited by 29
Siddaway, R., Canty, L., Pajovic, S., Milos, S., Coyaud, É., Sbergio, S.-G., Vadivel, A. K. A., Lubanszky, E., Yun, H. Y., Portante, A., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02489-2 · Cited by 27
Immisch, L., Papafotiou, G., Popp, O., Mertins, P., Blankenstein, T. J. F., & Willimsky, G. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005535 · Cited by 26
Amberg, N., Pauler, F. M., Streicher, C., & Hippenmeyer, S. (2022) · Science Advances · doi:10.1126/sciadv.abq1263 · Cited by 27
Pan-cancer atlas of somatic core and linker histone mutations
Bonner, E. R., Dawood, A., Gordish‐Dressman, H., Eze, A., Bhattacharya, S., Yadavilli, S., Mueller, S. C., Waszak, S. M., & Nazarian, J. (2023) · npj Genomic Medicine · doi:10.1038/s41525-023-00367-8 · Cited by 26
Shen, C., & Vakoc, C. R. (2014) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000151 · Cited by 26
Mechanisms of Nucleosome Dynamics In VivoPreprint
Henikoff, S. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026666 · Cited by 27
Bivalent chromatin instructs lineage specification during hematopoiesis
Yagi, M., Bonilla, G. M., Hoetker, M. S., Tsopoulidis, N., Horng, J. E., Haggerty, C., Meissner, A., Sadreyev, R. I., Hock, H. R., & Hochedlinger, K. (2025) · Cell · doi:10.1016/j.cell.2025.05.011 · Cited by 27
The complexity of epigenetic diseases
Brazel, A. J., & Vernimmen, D. (2015) · The Journal of Pathology · doi:10.1002/path.4647 · Cited by 25
Sasaki, T., Katagi, H., Goldman, S., Becher, O. J., & Hashizume, R. (2020) · Neurosurgery · doi:10.1093/neuros/nyaa301 · Cited by 25
Self-citationPerner, F., & Armstrong, S. A. (2020) · Cells · doi:10.3390/cells9122721 · Cited by 25
The Role of DNA Methylation and DNA Methyltransferases in Cancer
Weisenberger, D. J., Lakshminarasimhan, R., & Liang, G. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11454-0_13 · Cited by 27
Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma
Ocasio, J. K., Budd, K. M., Roach, J. T., Andrews, J. M., & Baker, S. J. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10105-2 · Cited by 27
A road map for the treatment of pediatric diffuse midline glioma
Koschmann, C. J., Al‐Holou, W. N., Alonso, M. M., Anastas, J. N., Bandopadhayay, P., Barron, T., Becher, O. J., Cartaxo, R. T., Castro, M. G., Chung, C., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.11.002 · Cited by 25
Self-citationClymer, J. R., & Kieran, M. W. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00169 · Cited by 25
Ge, E. J., Jani, K. S., Diehl, K. L., Müller, M. M., & Muir, T. W. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b02321 · Cited by 24
Self-citationMendez, F., Núñez, F. J., Garcia-Fabiani, M. B., Haase, S., Carney, S. V., Gauss, J. C., Becher, O. J., Lowenstein, P. R., & Castro, M. G. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz218 · Cited by 25
Self-citationCancer Stem Cells Activate STAT3 the EZ Way
Fouse, S. D., & Costello, J. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.016 · Cited by 25
Cancer of the Central Nervous System
Dorsey, J. F., Salinas, R. D., Dang, M. T., Alonso‐Basanta, M., Judy, K. D., Maity, A. M., Lustig, R. A., Lee, J. Y. K., Phillips∥, P. C., & Pruitt, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00063-3 · Cited by 26
PARticular MARks: Histone ADP-ribosylation and the DNA damage response
Özdemir, C., Purkey, L. R., Sanchez, A. R., & Miller, K. M. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103711 · Cited by 24
Weng, L., & Greenberg, M. M. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b05478 · Cited by 24
Investigational new drugs for brain cancer
Staedtke, V., Bai, R.-Y., & Laterra, J. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1182497 · Cited by 25
SETD2-dependent H3K36me3 plays a critical role in epigenetic regulation of the HPV31 life cycle
Gautam, D., Johnson, B. A., Mac, M., & Moody, C. A. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007367 · Cited by 25
Oncohistone Mutations in Diffuse Intrinsic Pontine Glioma
Zhang, X., & Zhang, Z. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.10.009 · Cited by 25
Waker, C. A., & Lober, R. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9636-7_18 · Cited by 24
Decrease of circARID1A retards glioblastoma invasion by modulating miR-370-3p/ TGFBR2 pathway
Li, B., Chen, J., Wu, Y., Luo, H., & Ke, Y. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.66673 · Cited by 24
Chen, J., Shan, S., Xia, B., Zhang, L., & Liang, X. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202302378 · Cited by 25
Maleszewska, M., & Kaminska, B. (2015) · Future Oncology · doi:10.2217/fon.15.171 · Cited by 24
Enhancer, epigenetics, and human disease
Luo, Z., & Lin, C. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.03.012 · Cited by 25
CDK4/6 and PDGFRA Signaling as Therapeutic Targets in Diffuse Intrinsic Pontine Glioma
Hoeman, C. M., Shen, C., & Becher, O. J. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00191 · Cited by 24
Self-citationKida, J., Tsujioka, T., Suemori, S., Okamoto, S., Sakakibara, K., Takahata, T., Yamauchi, T., Kitanaka, A., Tohyama, Y., & Tohyama, K. (2018) · Leukemia · doi:10.1038/s41375-018-0189-7 · Cited by 24
The Necessity of Chromatin: A View in PerspectivePreprint
Pirrotta, V. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019547 · Cited by 27
PRC2 loss amplifies Ras signaling in cancer
Baude, A., Lindroth, A. M., & Plass, C. (2014) · Nature Genetics · doi:10.1038/ng.3124 · Cited by 23
Polycomb group proteins in cancer: multifaceted functions and strategies for modulation
Wang, S. P., Ordonez‐Rubiano, S. C., Dhiman, A., Jiao, G., Strohmier, B. P., Krusemark, C. J., & Dykhuizen, E. C. (2021) · NAR Cancer · doi:10.1093/narcan/zcab039 · Cited by 27
Day, C. A., Hinchcliffe, E. H., & Robinson, J. (2022) · Cells · doi:10.3390/cells11213376 · Cited by 24
Superenhancers as master gene regulators and novel therapeutic targets in brain tumors
Zhuang, H.-H., Qu, Q., Teng, X.-Q., Dai, Y.-H., & Qu, J. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00934-0 · Cited by 24
Cencioni, C., Scagnoli, F., Spallotta, F., Nasi, S., & Illi, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044217 · Cited by 28
Proteomic profiling identifies specific histone species associated with leukemic and cancer cells
Singh, R., Harshman, S. W., Ruppert, A. S., Mortazavi, A., Lucas, D. M., Thomas‐Ahner, J. M., Clinton, S. K., Byrd, J. C., Freitas, M. A., & Parthun, M. R. (2015) · Clinical Proteomics · doi:10.1186/s12014-015-9095-4 · Cited by 23
Type II CRISPR/Cas9 approach in the oncological therapy
Biagioni, A., Chillà, A., Andreucci, E., Laurenzana, A., Margheri, F., Peppicelli, S., Rosso, M. D., & Fibbi, G. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0550-0 · Cited by 23
Delaney, K., Strobino, M., Wenda, J. M., Pankowski, A., & Steiner, F. A. (2019) · Nature Communications · doi:10.1038/s41467-019-10404-9 · Cited by 22
Koncar, R. F., Dey, B., Stanton, A.-C. J., Agrawal, N., Wassell, M., McCarl, L. H., Locke, A. L., Sanders, L., Vaske, O. M., Myers, M. I., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3521 · Cited by 23
Self-citationPreclinical therapeutic targets in diffuse midline glioma
Meel, M. H., Kaspers, G. J. L., & Hulleman, E. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.06.001 · Cited by 23
Dynamic Signatures of the Epigenome: Friend or Foe?
Machnik, M., & Oleksiewicz, U. (2020) · Cells · doi:10.3390/cells9030653 · Cited by 23
Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy
Graham, M. S., & Mellinghoff, I. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197193 · Cited by 24
Wassef, M. A., Michaud, A., & Margueron, R. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1208872 · Cited by 25
Brain Tumors: Challenges and Opportunities to Cure
Mellinghoff, I. K., & Gilbertson, R. J. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.2965 · Cited by 22
Wang, C. Y., Sinha, S., Jiang, X., Fitch, S., Wilson, C., Caretti, V., Ponnuswami, A., Monje, M., Grant, G. A., & Yang, F. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.09.007 · Cited by 20
Diffuse Gliomas of the Brainstem and Cerebellum in Adults Show Molecular Heterogeneity
Eschbacher, K. L., Ida, C. M., Johnson, D. R., Alvi, M. A., Jenkins, S. M., Ruff, M. W., Kerezoudis, P., Neth, B. J., Pasion, R. M., Daniels, D. J., et al. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001690 · Cited by 22
Banday, A. R., Baumgartner, M., Seesi, S. A., Karunakaran, D. K. P., Venkatesh, A., Congdon, S., Lemoine, C., Kilcollins, A. M., Măndoiu, I., Punzo, C., et al. (2014) · Cell Cycle · doi:10.4161/15384101.2015.941757 · Cited by 22
Akkad, D., Gerding, W. M., Gasser, R., & Epplen, J. (2015) · Canine Genetics and Epidemiology · doi:10.1186/s40575-015-0018-5 · Cited by 17
Sturm, D., & Filbin, M. G. (2018) · Seminars in Neurology · doi:10.1055/s-0038-1635106 · Cited by 22
Modeling cancer progression using human pluripotent stem cell-derived cells and organoids
Zhang, M., Vandana, J. J., Lacko, L. A., & Chen, S. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.102063 · Cited by 23
Forsyth, R. G., Krenács, T., Athanasou, N. A., & Hogendoorn, P. C. W. (2021) · Cancers · doi:10.3390/cancers13205119 · Cited by 23
Adult H3K27M-mutant diffuse midline glioma with gliomatosis cerebri growth pattern
Yekula, A., Gupta, M., Coley, N., & Hoi Sang, U. (2020) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2020.02.046 · Cited by 22
Wang, N., Pachai, M. R., Li, D., Lee, C. J., Warda, S., Khudoynazarova, M. N., Cho, W. H., Xie, G., Shah, S. R., Li, Y., et al. (2025) · Nature Genetics · doi:10.1038/s41588-024-02015-y · Cited by 25
Goncalves, T., Cunniffe, S. M. T., Ma, T. S., Mattis, N., Rose, A. W., Kent, T., Mole, D. R., Geiller, H. E. B., van Bijsterveldt, L., Humphrey, T. C., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf061 · Cited by 20
Histone isoforms and the oncohistone code
Flaus, A., Downs, J. A., & Owen‐Hughes, T. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.11.003 · Cited by 21
Banan, R., Akbarian, A., Samii, M., Samii, A., Bertalanffy, H., Lehmann, U., Hartmann, C. J., & Brüning, R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249647 · Cited by 21
Tumor-Associated Microenvironment of Adult Gliomas: A Review
Nunno, V. D., Franceschi, E., Tosoni, A., Gatto, L., Bartolini, S., & Brandes, A. A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.891543 · Cited by 22
Oncohistones in brain tumors: the soil and seed
Andrade, A. F., Chen, C. C. L., & Jabado, N. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.02.003 · Cited by 21
Catalytic and non-catalytic mechanisms of histone H4 lysine 20 methyltransferase SUV420H1
Abini-Agbomson, S., Gretarsson, K. H., Shih, R. M., Hsieh, L. J., Lou, T., Ioannes, P. D., Vasilyev, N., Lee, R., Wang, M., Simon, M. D., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.07.020 · Cited by 24
Chemotherapy in pediatric brain tumor and the challenge of the blood–brain barrier
Reza, M. J., Podany, A. T., Κhan, P., Shaffer, C. L., Siddiqui, J. A., Baranowska‐Kortylewicz, J., Lê, J., Fletcher, C. V., Ether, S. A., & Avedissian, S. N. (2023) · Cancer Medicine · doi:10.1002/cam4.6647 · Cited by 22
Landais, S., D’Alterio, C., & Jones, D. L. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.042 · Cited by 21
Rpp29 regulates histone H3.3 chromatin assembly through transcriptional mechanisms
Shastrula, P. K., Lund, P. J., Garcia, B. A., & Janicki, S. M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001845 · Cited by 21
Self-citationBailey, C. P., Figueroa, M., Mohiuddin, S., Zaky, W. T., & Chandra, J. (2018) · Bioengineering · doi:10.3390/bioengineering5040088 · Cited by 21
McCann, T. S., Sobral, L. M., Self, C., Hsieh, J. C. Y., Sechler, M., & Jedlicka, P. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1580692 · Cited by 21
Venneker, S., Szuhai, K., Hogendoorn, P. C. W., & Bovée, J. V. M. G. (2019) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-019-02699-2 · Cited by 21
DNA mismatch repair in the context of chromatin
Huang, Y., & Li, G. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-0379-7 · Cited by 21
Liao, X., Zhou, Z., & Zhang, X. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11142 · Cited by 21
H3K36 methylation regulates cell plasticity and regeneration in the intestinal epithelium
Swearingen, A. R., Meyer, A. R., Bussey-Sutton, C. R., O’Connor, E. S., Coradin, M., Coulombe, M., Riemondy, K. A., Potlapelly, S., Strahl, B. D., Hansson, G. C., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-024-01580-y · Cited by 23
Recurrent H3.3 alterations in childhood tumors
Lindroth, A. M., & Plass, C. (2013) · Nature Genetics · doi:10.1038/ng.2832 · Cited by 20
The growing role of epigenetics in childhood cancers
Panditharatna, E., & Filbin, M. G. (2019) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000867 · Cited by 19
Paro, R., Grossniklaus, U., Santoro, R., & Wutz, A. (2021) · Learning materials in biosciences · doi:10.1007/978-3-030-68670-3 · Cited by 26
H3G34-Mutant Gliomas—A Review of Molecular Pathogenesis and Therapeutic Options
Nguyen, A. V. P., Soto, J. M., Gonzalez, S.-M. C., Murillo, J., Trumble, E. R., Shan, F. Y., & Huang, J. H. (2023) · Biomedicines · doi:10.3390/biomedicines11072002 · Cited by 22
Knockout tales: the versatile roles of histone H3.3 in development and disease
Klein, R. H., & Knoepfler, P. S. (2023) · Epigenetics & Chromatin · doi:10.1186/s13072-023-00512-8 · Cited by 21
Pediatric glioma histone H3.3 K27M/G34R mutations drive abnormalities in PML nuclear bodies
Voon, H. P. J., Hii, L. L., Garvie, A., Udugama, M., Krug, B., Russo, C., Chüeh, A. C., Daly, R. J., Morey, A., Bell, T. D. M., et al. (2023) · Genome biology · doi:10.1186/s13059-023-03122-5 · Cited by 20
Recognition of cancer mutations in histone H3K36 by epigenetic writers and readers
Klein, B. J., Krajewski, K., Restrepo, S., Lewis, P. W., Strahl, B. D., & Kutateladze, T. G. (2018) · Epigenetics · doi:10.1080/15592294.2018.1503491 · Cited by 24
Self-citationLoveson, K. F., & Fillmore, H. L. (2018) · Brain Sciences · doi:10.3390/brainsci8110200 · Cited by 21
H4K20 monomethylation inhibition causes loss of genomic integrity in mouse preimplantation embryos
Shikata, D., Yamamoto, T., Honda, S., Ikeda, S., & Minami, N. (2020) · Journal of Reproduction and Development · doi:10.1262/jrd.2020-036 · Cited by 17
Partap, S., & Monje, M. (2020) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000955 · Cited by 21
UBR7 acts as a histone chaperone for post‐nucleosomal histone H3
Hogan, A., Sathyan, K. M., Willis, A. B., Khurana, S., Srivastava, S., Zasadzińska, E., Lee, A. S., Bailey, A. O., Gaynes, M. N., Huang, J., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108307 · Cited by 21
Alterations of Histone Modifications in Cancer
Hosseini, A., & Minucci, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812215-0.00006-6 · Cited by 22
Chromatin Mechanisms Driving CancerPreprint
Gryder, B. E., Scacheri, P. C., Ried, T., & Khan, J. I. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040956 · Cited by 20
Watanabe, J., Clutter, M. R., Gullette, M. J., Sasaki, T., Uchida, E., Kaur, S., Mo, Y., Abe, K., Ishi, Y., Takata, N., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci174794 · Cited by 21
Self-citationGue, R., & Lakhani, D. A. (2024) · Biomedicines · doi:10.3390/biomedicines12061349 · Cited by 23
Green, A. L., Flannery, P. C., Hankinson, T. C., O’Neill, B. R., Amani, V. M., DeSisto, J. A., Knox, A. J., Chatwin, H. V., Lemma, R., Hoffman, L. M., et al. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa021 · Cited by 19
Polycomb and Trithorax Group Proteins: The Long Road from Mutations in Drosophila to Use in Medicine
Chetverina, D., Ломаев, Д. В., & Erokhin, M. (2020) · Acta Naturae · doi:10.32607/actanaturae.11090 · Cited by 18
The H3.3K27M oncohistone antagonizes reprogramming in Drosophila
Ahmad, K., & Henikoff, S. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009225 · Cited by 22
Diffuse Intrinsic Pontine Gliomas
Bredlau, A. L., & Korones, D. N. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800249-0.00006-8 · Cited by 19
CHD2 Regulates Neuron–Glioma Interactions in Pediatric Glioma
Zhang, X., Duan, S., Apostolou, P. E., Wu, X., Watanabe, J., Gallitto, M., Barron, T., Taylor, K. R., Woo, P. J., Hua, X., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0012 · Cited by 24
Stegat, L., Eckhardt, A., Gocke, A., Neyazi, S., Pohl, L., Schmid, S., Dottermusch, M., Frank, S., Pinnschmidt, H. O., Herms, J. W., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02800-3 · Cited by 19
Decoding the functional impact of the cancer genome through protein–protein interactions
Fu, H., Mo, X., & Ivanov, A. A. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-024-00784-6 · Cited by 22
Peptide inhibition of the SETD6 methyltransferase catalytic activity
Feldman, M., & Levy, D. (2017) · Oncotarget · doi:10.18632/oncotarget.23591 · Cited by 17
Histone H3.3K27M Mobilizes Multiple Cancer/Testis (CT) Antigens in Pediatric Glioma
Deng, H., Zeng, J., Zhang, T., Gong, L., Zhang, H., Cheung, E. C. W., Jones, C., & Li, G. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0460 · Cited by 19
Introduction to the Thematic Minireview Series: Chromatin and transcription
Gottesfeld, J., & Carey, M. F. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.tm118.004544 · Cited by 16
Chromatin Manipulation and Editing: Challenges, New Technologies and Their Use in Plants
Fal, K., Tomková, D., Vachon, G., Chabouté, M., Berr, A., & Carles, C. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020512 · Cited by 19
Metadata
- Authors
- Lewis, P. W., Müller, M. M., Koletsky, M. S., Cordero, F., Lin, S., Banaszynski, L. A., Garcia, B. A., Muir, T. W., Becher, O. J., & Allis, C. D.
- Affiliations
- Rockefeller University (US)
- Princeton University (US)
- Duke University (US)
- University of Pennsylvania (US)
- Corresponding author
- Allis, C. David
- ORCID
- Venue
- Science
- Published
- 2013-05-17
- Volume
- 340
- Issue
- 6134
- Pages
- 857-861
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3951439
- OpenAlex
- W1995105508
- Cited by
- 1,345
- References
- 14
- Citations by year
- 2026: 73 · 2025: 82 · 2024: 103 · 2023: 106 · 2022: 103 · 2021: 118 · 2020: 146 · 2019: 112 · 2018: 84 · 2017: 102 · 2016: 90 · 2015: 95 · 2014: 87 · 2013: 40
- FWCI
- 51.21
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Institutes of Health (DP2OD007447)
- National Institute of Mental Health (P50MH096890)
- National Institute of General Medical Sciences (GM040922, R01GM107047, R01GM040922)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- pediatric glioblastoma, diffuse intrinsic pontine glioma, H3K27M mutation, histone H3.3, H3K27me3, polycomb repressive complex 2, EZH2, histone methylation, gain-of-function mutations, epigenetic regulation
- MeSH terms
- Enhancer of Zeste Homolog 2 Protein, Animals, Brain Neoplasms, Child, Glioblastoma, Histones, Humans, Lysine, Methionine, Methylation, Transgenes, Amino Acid Substitution, Mutation, Missense, Epigenesis, Genetic, Mice, HEK293 Cells, Polycomb Repressive Complex 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
